Navigation Links
Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010
Date:3/15/2011

).

Financial Highlights for the Three Months Ended December 31, 2010

  • Revenue increased 7.7% to $50.0 million from $46.5 million in the prior year period.
  • Revenue from Healthcare Services increased 21% to $26.1 million, from $21.6 million in the prior year period. 
  • Net income for the quarter ended December 31, 2010 was $1.7 million, or $0.10 per diluted share, compared to net income of $3.9 million, or $0.24 per diluted share, in the prior year period.  

  • Three Months Ended December 31, 2010 ConsolidatedFinancial ResultsRevenue in the three months ended December 31, 2010 increased 7.5% to $50.0 million from $46.5 million in the prior year period, and reflects growing inpatient and outpatient volume across the United Family Healthcare network.  

    Income from operations in the quarter ended December 31, 2010 was $2.7 million, compared to income from operations of $6.6 million in the same quarter last year.  Total operating costs and expenses for the quarter ended December 31, 2010 increased to $47.2 million compared to $39.9 million in the prior year period.

    The variance in income from operations between the two periods of $3.8 million was primarily due to two items. First, during the three months ended December 31, 2010, the Company completed the formation of the CML joint venture with FosunPharma. Related to this transaction, Chindex incurred $942,000 in legal and professional fees which was recorded in general and administrative expenses. Second, in the prior year period, the Company recorded a benefit of $3.2 million to healthcare services costs to reflect the effect of business tax refunds, and had no similar benefit in the current period.

    Operating expenses included $1.0 million of non-cash stock compensation expense compared to $889,000 in the prior year.  Development, startup, and post-opening expenses in the Healthcare Services division were $
    '/>"/>

    SOURCE Chindex International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Chindex International to Report Financial Results for the Three and Nine-Month Periods Ended December 31, 2010
    2. Chindex and Fosun Pharma Form Joint Venture
    3. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2011 Financial Results
    4. Fosun Pharma Acquires $14 Million of Chindex Stock
    5. Chindex International to Report First Quarter 2011 Financial Results
    6. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results
    7. Chindex International to Report Third Quarter Fiscal Year 2010 Financial Results
    8. Chindex International to Present at Piper Jaffray Health Care Conference
    9. Chindex International Announces Participation in Brean Murray, Carret & Co. 2009 China Growth Conference
    10. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
    11. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/1/2015)... and Markets ( http://www.researchandmarkets.com/research/63gppw/asian_dermatology ) has announced the ... by End User - Forecast to 2019" report to ... estimated to grow at a CAGR of 11.3% from 2014 ... share in the Dermatology devices market around 28.8% in 2014 ... Devices market holds a high potential for growth in future ...
    (Date:5/1/2015)... At the American Association of Neurological Surgeons (AANS) Annual ... , Elekta will highlight Leksell Gamma Knife® Registry ... enormous amount of data – generated by thousands of ... advance clinical research and further optimize patient care. ... allows practitioners to store, retrieve, and analyze Gamma Knife ...
    (Date:5/1/2015)... Calif., May 1, 2015 Pharmacyclics, Inc. (the ... for the quarter ended March 31, 2015, as well ... AbbVie Inc., no conference call will be held. ... quarter ended March 31, 2015 increased to $206 million ... 2014. , Worldwide IMBRUVICA ® (ibrutinib) net ...
    Breaking Medicine Technology:Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 3Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 26Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 27Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 28Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 29Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 30Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 31Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 32
    (Date:5/2/2015)... As one of only 30 Illinois companies to ... Achievement and Recognition Program (SHARP) certification, Essentra Specialty ... Illinois Department of Labor to host this special event. ... by the Occupational Safety and Health Administration’s (“OSHA”) Onsite ... meet or exceed all of the necessary regulations and ...
    (Date:5/2/2015)... York, NY (PRWEB) May 02, 2015 ... when a deadly natural disaster strikes anywhere on this ... to leverage human sympathy and compassion for their own ... (United States Computer Emergency Readiness Team) issued an ... users “of potential email scams citing the earthquake in ...
    (Date:5/2/2015)... As a nonsurgical staple in the ... neck and décolleté, radiofrequency energy is proving to ... the success of vulvovaginal rejuvenation. In a pilot ... ThermiGyn’s Women’s Health Clinical Advisory Board Chairman Red ... temperature controlled radio frequency, specifically that of ThermiVa, ...
    (Date:5/1/2015)... 2015 Pioneer Millworks, the largest reclaimed ... in their reclaimed wood products at the 27th annual ... Center in NYC this May. Their newest offerings, Vat ... anticipated texture and color to North America's platform for ... texture and color in the design world and we're ...
    (Date:5/1/2015)... (PRWEB) May 01, 2015 It’s raining bills ... House introducing proposals to expand federal support for telemedicine. ... that ATA has been working with Congress,” said Jonathan Linkous, ... signify how the nation is poised to embrace the use ... one more step in fulfilling ATA’s mission to improve quality, ...
    Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2
    ... Services Panel That,Nursing Home Staffing and Quality Programs Are ... testimony,before a field hearing of the House Human Services ... (THCA) said that in order to,protect the Houston area,s ... essential in the year ahead to initiate a much-needed,discussion ...
    ... (IOF) has welcomed the recently published paper European ... in postmenopausal women(1) from the European Society for ... (ESCEO). , This paper constitutes a roadmap for ... tool based on the WHO technical report, Assessment ...
    ... access to top U.S. hospitals and doctors competing on the ... basis of quality, ... America (HPAM) offers,a specialty network for high value medical procedures ... rated medical centers,of excellence throughout the United States. These providers ...
    ... Online Ads, Bilingual Radio,Jingles, Resources for Parents, Older ... The Health Resources,and Services Administration (HRSA) has ... National Poison Prevention Week, March 16-22., The ... in the United States. This past year, more ...
    ... The American Academy of Cosmetic Surgery 2007 Procedural Survey ... 2226.3% increase in male sclerotherapy since ... of Cosmetic,Surgery (AACS) is pleased to announce the results ... polling the Academy,s U.S.-based,members., Findings conclude that sclerotherapy, ...
    ... the only curative treatment in patients with bile ... reliable diagnostic procedure is of great importance in ... the bile duct, imaging techniques including ultrasound, computed ... sensitivity for the detection of bile duct cancer. ...
    Cached Medicine News:Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 2Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 3Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 4Health News:IOF recognizes ESCEO European guidance for osteoporosis diagnosis and management 2Health News:The Healthplace America(TM) Benefit Delivers a Better Option in Healthcare 2Health News:HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 2Health News:Men are Opting to Remove Spider Veins Over Replacing Hair 2
    ... Harmony Special Peristaltic phacoemulsification system features microprocessor ... individual programmability and remote control for all ... front panel with color coded function modes ... ease of use and viewing. Under control ...
    The D.O.R.C. Silicone Oil is an ultra purified silicone oil which leads a maximum interfacial tension and minimizes interactions between tissues, cells and endo-tamponades media. (Sterile, 10 ml.)...
    Eftiar® offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and controlling r...
    Silver Foley Catheter 2-way...
    Medicine Products: